FierceBiotech ١٥ أبريل ٢٠٢٦ Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech ٢٧ مارس ٢٠٢٦ Novartis pens $2B deal for allergy biotech with potential Xolair successor
Endpoints News ٢٧ مارس ٢٠٢٦ Novartis to spend up to $2B on Excellergy and its next-gen Xolair candidate
Endpoints News ٢٥ مارس ٢٠٢٦ Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis' Scemblix
Endpoints News ٢٣ مارس ٢٠٢٦ Novartis to invest $480M in China following AstraZeneca and Lilly pledges
FierceBiotech ٢٣ مارس ٢٠٢٦ Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
FierceBiotech ٢٠ مارس ٢٠٢٦ Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
Endpoints News ٢٠ مارس ٢٠٢٦ Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Endpoints News ١٦ مارس ٢٠٢٦ After Novartis pact, macrocycle shop Unnatural Products gets $45M Series B
FierceBiotech ٢٧ فبراير ٢٠٢٦ Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates